Workflow
百奥泰发布前三季度业绩,归母净亏损2.24亿元
Bio-TheraBio-Thera(SH:688177) 智通财经网·2025-10-28 13:22

Core Insights - Baotai (688177.SH) reported a revenue of 684 million yuan for the first three quarters of 2025, representing a year-on-year growth of 17.57% [1] - The company recorded a net loss attributable to shareholders of 224 million yuan [1] - The non-recurring net profit loss was 279 million yuan, with a basic earnings per share of -0.54 yuan [1]